Drugs / GBS glycoconjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00645346 | Feb 2008 → May 2009 | group B streptococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GBS glycoconjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00645346 ↗ |
| Modality | Vaccine | “GBS vaccine” NCT00645346 ↗ |